Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
hUC-MSC therapy (DVC Stem)
- Development stage
- Preclinical
- Lead developer
- DVC Stem
- Modality
- Stem Cell Therapies → Cell Therapies
- Administration
- Intravenous
01
Overview
DVC Stem's mesenchymal stem cell therapy is an allogeneic cell therapy utilizing human umbilical cord tissue-derived mesenchymal stem cells (hUC-MSCs). The treatment involves the intravenous infusion of approximately 300 million culturally expanded MSCs, which are sourced from cGMP-compliant, FDA-registered laboratories in the United States. The therapy is designed to address systemic inflammation and promote tissue repair through paracrine signaling, immunomodulation, and potential cell differentiation. It is primarily indicated for degenerative conditions such as chronic obstructive pulmonary disease (COPD), liver disease, and asbestosis, as well as for 'Intelligent Aging' protocols aimed at improving longevity and reducing age-related inflammation. The protocol is registered with the Cayman Islands government and is IRB-approved, operating as a clinical treatment rather than a traditional phased pharmaceutical trial.
- Other names
- human umbilical cord tissue-derived mesenchymal stem cellsallogeneic cord-derived MSCshUC-MSCs
Beyond the preview
Go deeper on hUC-MSC therapy (DVC Stem).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on hUC-MSC therapy (DVC Stem).